Cisatracurium Besylate Market

Cisatracurium besylate is the latest generation of muscle relaxant. Compared with the major clinical muscle relaxants, this product has the characteristics of metabolism through non-hepatic and non-renal pathways and cardiovascular stability.Atracurium is mainly used in general anesthesia, and can be widely used in endotracheal intubation, liver and kidney dysfunction, cardiovascular surgery and elderly and pediatric patients.Since the drug was first marketed in the UK in 1996, it has gradually replaced vecuronium bromide and atracurium in foreign countries and become the mainstream of clinical muscle relaxants.

Cisatracurium Besylate Market contains market size and forecasts of Cisatracurium Besylate in global, including the following market information:

Global Cisatracurium Besylate Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Cisatracurium Besylate Market Sales, 2017-2022, 2023-2028, (Litre)

Global top five Cisatracurium Besylate companies in 2021 (%)

The global Cisatracurium Besylate market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Solution Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cisatracurium Besylate include GSK, Aspen Pharmacare, AbbVie, Abbott, Pfizer, Mylan Pharmaceuticals, Fresenius Kabi, Omega Laboratories Ltd and Somerset Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Cisatracurium Besylate manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cisatracurium Besylate Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Litre)

Global Cisatracurium Besylate Market Segment Percentages, by Type, 2021 (%)

Solution

Injection

Global Cisatracurium Besylate Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Litre)

Global Cisatracurium Besylate Market Segment Percentages, by Application, 2021 (%)

General Anesthesia

Endotracheal Intubation

Liver And Kidney Dysfunction

Cardiovascular Surgery

Old Families

Pediatric

Other

Global Cisatracurium Besylate Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Litre)

Global Cisatracurium Besylate Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Cisatracurium Besylate revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Cisatracurium Besylate revenues share in global market, 2021 (%)

Key companies Cisatracurium Besylate sales in global market, 2017-2022 (Estimated), (Litre)

Key companies Cisatracurium Besylate sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

GSK

Aspen Pharmacare

AbbVie

Abbott

Pfizer

Mylan Pharmaceuticals

Fresenius Kabi

Omega Laboratories Ltd

Somerset Therapeutics

Jiangsu Hengrui Medicine

Shanghai Pharmaceuticals Holding

Zhejiang Xianju